Quest Diagnostics (NYSE:DGX) Has Some Way To Go To Become A Multi-Bagger
Quest Diagnostics (NYSE:DGX) Has Some Way To Go To Become A Multi-Bagger
There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. So, when we ran our eye over Quest Diagnostics' (NYSE:DGX) trend of ROCE, we liked what we saw.
如果我們想確定下一款多袋機,有一些關鍵的趨勢需要考慮。首先,我們希望確定不斷增長的已動用資本回報率(ROCE),然後確定不斷增加的資本使用基礎。如果你看到這一點,這通常意味着它是一家擁有良好商業模式和大量盈利再投資機會的公司。因此,當我們關注Quest Diagnostics(紐約證券交易所代碼:DGX)的ROCE趨勢時,我們喜歡我們所看到的。
What Is Return On Capital Employed (ROCE)?
什麼是資本使用回報率(ROCE)?
If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. The formula for this calculation on Quest Diagnostics is:
如果你以前沒有與ROCE合作過,它會衡量公司從其業務中使用的資本中產生的 「回報」(稅前利潤)。Quest Diagnostics 的計算公式爲:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
已動用資本回報率 = 息稅前收益 (EBIT) ¥(總資產-流動負債)
0.11 = US$1.3b ÷ (US$14b - US$2.3b) (Based on the trailing twelve months to March 2024).
0.11 = 13億美元 ÷(140億美元至23億美元)(基於截至2024年3月的過去十二個月)。
Thus, Quest Diagnostics has an ROCE of 11%. That's a pretty standard return and it's in line with the industry average of 11%.
因此,Quest Diagnostics的投資回報率爲11%。這是一個相當標準的回報率,與11%的行業平均水平一致。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240723/0-10e0769e6d7cd4341dbb412f2ea26420-0-09101019109706d8a0c86f05c74a0ea4.png/big)
In the above chart we have measured Quest Diagnostics' prior ROCE against its prior performance, but the future is arguably more important. If you'd like, you can check out the forecasts from the analysts covering Quest Diagnostics for free.
在上圖中,我們將Quest Diagnostics之前的投資回報率與之前的表現進行了比較,但可以說,未來更爲重要。如果你願意,你可以免費查看報道Quest Diagnostics的分析師的預測。
So How Is Quest Diagnostics' ROCE Trending?
那麼 Quest Diagnostics 的 ROCE 趨勢如何呢?
While the returns on capital are good, they haven't moved much. The company has employed 21% more capital in the last five years, and the returns on that capital have remained stable at 11%. 11% is a pretty standard return, and it provides some comfort knowing that Quest Diagnostics has consistently earned this amount. Over long periods of time, returns like these might not be too exciting, but with consistency they can pay off in terms of share price returns.
儘管資本回報率不錯,但變化不大。在過去五年中,該公司僱用的資本增加了21%,該資本的回報率一直穩定在11%。11%是一個相當標準的回報率,知道Quest Diagnostics一直賺取這筆錢,這讓人感到欣慰。在很長一段時間內,這樣的回報可能不會太令人興奮,但只要保持一致,它們可以在股價回報方面獲得回報。
The Bottom Line On Quest Diagnostics' ROCE
Quest Diagnostics 的 ROCE 的底線
The main thing to remember is that Quest Diagnostics has proven its ability to continually reinvest at respectable rates of return. Therefore it's no surprise that shareholders have earned a respectable 59% return if they held over the last five years. So while the positive underlying trends may be accounted for by investors, we still think this stock is worth looking into further.
要記住的主要事情是,Quest Diagnostics已經證明了其以可觀的回報率持續進行再投資的能力。因此,股東在過去五年中持股後獲得可觀的59%回報率也就不足爲奇了。因此,儘管積極的潛在趨勢可能由投資者解釋,但我們仍然認爲該股值得進一步研究。
Like most companies, Quest Diagnostics does come with some risks, and we've found 1 warning sign that you should be aware of.
像大多數公司一樣,Quest Diagnostics確實存在一些風險,我們發現了一個你應該注意的警告信號。
For those who like to invest in solid companies, check out this free list of companies with solid balance sheets and high returns on equity.
對於那些喜歡投資穩健公司的人,可以查看這份資產負債表穩健和股本回報率高的公司的免費清單。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
對這篇文章有反饋嗎?擔心內容嗎?直接聯繫我們。或者,發送電子郵件至 editorial-team@simplywallst.com